Td Private Client Wealth LLC Biogen Inc. Transaction History
Td Private Client Wealth LLC
- $3.63 Trillion
- Q1 2025
A detailed history of Td Private Client Wealth LLC transactions in Biogen Inc. stock. As of the latest transaction made, Td Private Client Wealth LLC holds 12 shares of BIIB stock, worth $1,582. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12
Previous 52
76.92%
Holding current value
$1,582
Previous $7.95 Million
79.35%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding BIIB
# of Institutions
1,026Shares Held
127MCall Options Held
2.29MPut Options Held
4.26M-
Vanguard Group Inc Valley Forge, PA17MShares$2.25 Billion0.04% of portfolio
-
Primecap Management CO Pasadena, CA15.9MShares$2.1 Billion1.84% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$1.92 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.4MShares$975 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA4.67MShares$616 Million0.13% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $19B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...